Cargando…
Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
INTRODUCTION: Hepatitis C virus (HCV) is a major cause of chronic liver disease in Egypt, leading to hepatic fibrosis, liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Liver fibrosis is characterized by excessive deposition of extracellular matrix (ECM). Newly-recognized pathogenic mechanis...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Electronic physician
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725417/ https://www.ncbi.nlm.nih.gov/pubmed/26816590 http://dx.doi.org/10.19082/1626 |
_version_ | 1782411639206707200 |
---|---|
author | Zoheiry, Mona M Hasan, Shaimaa AA El-Ahwany, Eman Nagy, Faten M Taleb, Hoda Abu Nosseir, Mona Magdy, Mona Meshaal, Safa EL-Talkawy, Mohamed Darwish Raafat, Inas |
author_facet | Zoheiry, Mona M Hasan, Shaimaa AA El-Ahwany, Eman Nagy, Faten M Taleb, Hoda Abu Nosseir, Mona Magdy, Mona Meshaal, Safa EL-Talkawy, Mohamed Darwish Raafat, Inas |
author_sort | Zoheiry, Mona M |
collection | PubMed |
description | INTRODUCTION: Hepatitis C virus (HCV) is a major cause of chronic liver disease in Egypt, leading to hepatic fibrosis, liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Liver fibrosis is characterized by excessive deposition of extracellular matrix (ECM). Newly-recognized pathogenic mechanisms point to the epithelial-mesenchymal transition (EMT) of hepatocytes to matrix synthesizing (myo-) fibroblasts. Transforming growth factor-beta (TGF-β1), bone morphogenic protein (BMP)-7, and connective tissue growth factor (CTGF) are biomarkers reflecting the EMT process. YKL-40 is a glycoprotein member of ECM and plays a role in cancer cell proliferation. The purpose of this study was to determine the serum biomarkers of EMT and its impact on the fibrogenic process and tumorigenesis in HCV-genotype 4 patients. METHODS: In this case-control study that was conducted in 2013–2014, 97 HCV-infected patients were subjected to clinical examination, laboratory investigations, and liver biopsy. According to the histopathologic examination, they were classified to F0 (14 cases), F1 (17 cases), F2 (15 cases), F3 (18 cases), F4 (22 cases), and HCC (11 cases). Fifteen age- and gender-matched subjects were included as normal controls. Serum levels of TGF-β1, BMP-7, CTGF, YKL-40 were assessed, and the TGF-β1/BMP-7 ratios were calculated. The data were analyzed by plotting the receiver operating characteristic curve (ROC), Pearson product-moment correlation coefficient, and Spearman’s rank correlation coefficient (Spearman’s rho). RESULTS: Serum levels of TGF-β1, BMP-7, CTGF, and YKL-40 were significantly increased in all patient groups compared to controls (p < 0.001). LC exhibited the highest CTGF level and YKL-40 was highest in HCC. The TGF-β1/ BMP-7 ratios reflected the progression of EMT from CHC to LC, however, there was no significant difference between LC and HCC. TGF-β1/ BMP-7 ratio is considered to reflect positive correlation with CTGF in LC group (r = 0.629; p < 0.03) and YKL-40 in HCC group (r = 0.504; p < 0.04). CONCLUSION: Increased TGF-β1/BMP-7 ratio and CTGF levels reflect the rate of EMT and provide information about fibrogenic activity. Also, this ratio, in association with YKL-40, can be used to predict malignant transformation in HCV-genotype 4 Egyptian patients. |
format | Online Article Text |
id | pubmed-4725417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Electronic physician |
record_format | MEDLINE/PubMed |
spelling | pubmed-47254172016-01-26 Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma Zoheiry, Mona M Hasan, Shaimaa AA El-Ahwany, Eman Nagy, Faten M Taleb, Hoda Abu Nosseir, Mona Magdy, Mona Meshaal, Safa EL-Talkawy, Mohamed Darwish Raafat, Inas Electron Physician Original Article INTRODUCTION: Hepatitis C virus (HCV) is a major cause of chronic liver disease in Egypt, leading to hepatic fibrosis, liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Liver fibrosis is characterized by excessive deposition of extracellular matrix (ECM). Newly-recognized pathogenic mechanisms point to the epithelial-mesenchymal transition (EMT) of hepatocytes to matrix synthesizing (myo-) fibroblasts. Transforming growth factor-beta (TGF-β1), bone morphogenic protein (BMP)-7, and connective tissue growth factor (CTGF) are biomarkers reflecting the EMT process. YKL-40 is a glycoprotein member of ECM and plays a role in cancer cell proliferation. The purpose of this study was to determine the serum biomarkers of EMT and its impact on the fibrogenic process and tumorigenesis in HCV-genotype 4 patients. METHODS: In this case-control study that was conducted in 2013–2014, 97 HCV-infected patients were subjected to clinical examination, laboratory investigations, and liver biopsy. According to the histopathologic examination, they were classified to F0 (14 cases), F1 (17 cases), F2 (15 cases), F3 (18 cases), F4 (22 cases), and HCC (11 cases). Fifteen age- and gender-matched subjects were included as normal controls. Serum levels of TGF-β1, BMP-7, CTGF, YKL-40 were assessed, and the TGF-β1/BMP-7 ratios were calculated. The data were analyzed by plotting the receiver operating characteristic curve (ROC), Pearson product-moment correlation coefficient, and Spearman’s rank correlation coefficient (Spearman’s rho). RESULTS: Serum levels of TGF-β1, BMP-7, CTGF, and YKL-40 were significantly increased in all patient groups compared to controls (p < 0.001). LC exhibited the highest CTGF level and YKL-40 was highest in HCC. The TGF-β1/ BMP-7 ratios reflected the progression of EMT from CHC to LC, however, there was no significant difference between LC and HCC. TGF-β1/ BMP-7 ratio is considered to reflect positive correlation with CTGF in LC group (r = 0.629; p < 0.03) and YKL-40 in HCC group (r = 0.504; p < 0.04). CONCLUSION: Increased TGF-β1/BMP-7 ratio and CTGF levels reflect the rate of EMT and provide information about fibrogenic activity. Also, this ratio, in association with YKL-40, can be used to predict malignant transformation in HCV-genotype 4 Egyptian patients. Electronic physician 2015-12-20 /pmc/articles/PMC4725417/ /pubmed/26816590 http://dx.doi.org/10.19082/1626 Text en © 2015 The Authors This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Original Article Zoheiry, Mona M Hasan, Shaimaa AA El-Ahwany, Eman Nagy, Faten M Taleb, Hoda Abu Nosseir, Mona Magdy, Mona Meshaal, Safa EL-Talkawy, Mohamed Darwish Raafat, Inas Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma |
title | Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma |
title_full | Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma |
title_fullStr | Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma |
title_full_unstemmed | Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma |
title_short | Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma |
title_sort | serum markers of epithelial mesenchymal transition as predictors of hcv-induced liver fibrosis, cirrhosis and hepatocellular carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725417/ https://www.ncbi.nlm.nih.gov/pubmed/26816590 http://dx.doi.org/10.19082/1626 |
work_keys_str_mv | AT zoheirymonam serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT hasanshaimaaaa serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT elahwanyeman serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT nagyfatenm serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT talebhodaabu serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT nosseirmona serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT magdymona serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT meshaalsafa serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT eltalkawymohameddarwish serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma AT raafatinas serummarkersofepithelialmesenchymaltransitionaspredictorsofhcvinducedliverfibrosiscirrhosisandhepatocellularcarcinoma |